Concentrix (NASDAQ:CNXC – Get Free Report) updated its second quarter 2026 earnings guidance on Thursday. The company provided EPS guidance of 2.570-2.690 for the period, compared to the consensus EPS estimate of 2.670. The company issued revenue guidance of $2.5 billion-$2.5 billion, compared to the consensus revenue estimate of $2.5 billion. Concentrix also updated its FY 2026 guidance to 11.480-12.070 EPS.
Analyst Upgrades and Downgrades
A number of brokerages have recently commented on CNXC. Weiss Ratings lowered Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research note on Thursday, January 29th. Wall Street Zen lowered Concentrix from a “buy” rating to a “hold” rating in a research note on Saturday, March 28th. Canaccord Genuity Group cut their price objective on Concentrix from $80.00 to $55.00 and set a “buy” rating on the stock in a research note on Wednesday, March 25th. Robert W. Baird cut their price objective on Concentrix from $52.00 to $40.00 and set an “outperform” rating on the stock in a research note on Wednesday, March 25th. Finally, Barrington Research cut their price objective on Concentrix from $62.00 to $38.00 and set an “outperform” rating on the stock in a research note on Wednesday, March 25th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Concentrix currently has a consensus rating of “Hold” and a consensus target price of $48.50.
Check Out Our Latest Research Report on CNXC
Concentrix Price Performance
Concentrix (NASDAQ:CNXC – Get Free Report) last issued its earnings results on Tuesday, March 24th. The company reported $2.61 earnings per share for the quarter, missing analysts’ consensus estimates of $2.65 by ($0.04). Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%.The business had revenue of $2.50 billion during the quarter, compared to the consensus estimate of $2.49 billion. During the same quarter in the previous year, the firm posted $2.79 earnings per share. The company’s revenue for the quarter was up 5.4% compared to the same quarter last year. As a group, research analysts expect that Concentrix will post 10.11 EPS for the current year.
Concentrix Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 5th. Shareholders of record on Friday, April 24th will be paid a $0.36 dividend. The ex-dividend date of this dividend is Friday, April 24th. This represents a $1.44 annualized dividend and a yield of 5.1%. Concentrix’s payout ratio is -6.68%.
Insider Activity at Concentrix
In other Concentrix news, CFO Andre S. Valentine purchased 2,500 shares of the company’s stock in a transaction on Thursday, April 9th. The shares were purchased at an average cost of $27.95 per share, with a total value of $69,875.00. Following the completion of the purchase, the chief financial officer owned 89,066 shares in the company, valued at $2,489,394.70. This represents a 2.89% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Christopher A. Caldwell purchased 1,000 shares of the company’s stock in a transaction on Thursday, January 29th. The stock was acquired at an average cost of $37.07 per share, for a total transaction of $37,070.00. Following the completion of the purchase, the chief executive officer owned 362,075 shares of the company’s stock, valued at approximately $13,422,120.25. This trade represents a 0.28% increase in their position. The SEC filing for this purchase provides additional information. 0.90% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Concentrix
Several institutional investors have recently added to or reduced their stakes in the business. Royal Bank of Canada increased its holdings in shares of Concentrix by 9.5% during the first quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock valued at $2,643,000 after acquiring an additional 4,133 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in shares of Concentrix by 75.1% during the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock valued at $23,552,000 after acquiring an additional 181,546 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in shares of Concentrix by 17.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock valued at $8,152,000 after acquiring an additional 21,746 shares in the last quarter. Focus Partners Wealth bought a new stake in shares of Concentrix during the first quarter valued at approximately $781,000. Finally, Geneos Wealth Management Inc. increased its holdings in shares of Concentrix by 532.7% during the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after acquiring an additional 522 shares in the last quarter. 90.34% of the stock is owned by institutional investors and hedge funds.
About Concentrix
Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.
Featured Stories
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.
